Researchers find no short-term link between saccharin and development of diabetes New research findings from The Ohio State University Wexner Medical Center found that the artificial sweetener saccharin did not alter the gut microbiota or induce glucose intolerance (an indicator of the development of diabetes) in healthy adults as previous studies have suggested.
The study, published in the journal
Microbiome, was supported by institutional funds from The National Institutes of Health, the National Institute of Food and Agriculture, and Advent-Health.
Saccharin and public health perception
Saccharin (one of the six artificial sweeteners approved by the FDA) is a zero-calorie, high-intensity, artificial sweetener 200 to 700 times sweeter than table sugar (sucrose) and has been used in formulations to sweeten beverages, jams, and baked goods. Its brand names include Sweet and Low, Sweet Twin, Sweet N Low, and Necta Sweet.